ABVC Biopharma Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Public

  • Employees
  • 19

Employees

  • Stock Symbol
  • ABVC

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $0.87
  • (As of Friday Closing)

ABVC Biopharma General Information

Description

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Contact Information

Formerly Known As
Ecology Coatings, American BriVision (Holding), OCIS, Metu Brands
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 44370 Old Warm Springs Boulevard
  • Fremont, CA 94538
  • United States
+1 (845)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 44370 Old Warm Springs Boulevard
  • Fremont, CA 94538
  • United States
+1 (845)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ABVC Biopharma Stock Performance

As of 20-Nov-2026, ABVC Biopharma’s stock price is $0.87. Its current market cap is $23.4M with 27M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.87 $0.88 $0.71 - $2.87 $23.4M 27M 81.8K -$0.15

ABVC Biopharma Financials Summary

As of 30-Sep-2026, ABVC Biopharma has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 32,806 55,330 8,963 11,782
Revenue 0 0 510 152
EBITDA (6,343) (7,599) (4,430) (6,516)
Net Income (3,915) (7,909) (4,903) (7,788)
Total Assets 20,296 21,062 7,540 7,784
Total Debt 2,511 3,473 2,431 2,595
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ABVC Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ABVC Biopharma‘s full profile, request access.

Request a free trial

ABVC Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices
Drug Discovery
Fremont, CA
19 As of 2025

San Diego, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ABVC Biopharma Competitors (7)

One of ABVC Biopharma’s 7 competitors is Cidara Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cidara Therapeutics Formerly VC-backed San Diego, CA
Nektar Therapeutics Formerly VC-backed San Francisco, CA
Genentech Formerly VC-backed South San Francisco, CA
Novartis Corporation Basel, Switzerland
Bright Angel Therapeutics Venture Capital-Backed Toronto, Canada
You’re viewing 5 of 7 competitors. Get the full list »

ABVC Biopharma Patents

ABVC Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2767935-A1 Coated substrates and methods of preparing the same Inactive 31-Jul-2009
EP-2459016-A2 Coated substrates and methods of preparing the same Inactive 31-Jul-2009
WO-2011014831-A2 Coated substrates and methods of preparing the same Inactive 31-Jul-2009
WO-2011014831-A3 Coated substrates and methods of preparing the same Inactive 31-Jul-2009
US-20080254303-A1 Actinic radiation curable; solvent-free dispersion containing amorphous silica filler Inactive 10-Apr-2007 C09D4/00
To view ABVC Biopharma’s complete patent history, request access »

ABVC Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ABVC Biopharma Investments & Acquisitions (6)

ABVC Biopharma’s most recent deal was a Corporate Asset Purchase with ABVC Biopharma (Land in Puli, Nantou County, Taiwan) for . The deal was made on 01-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ABVC Biopharma (Land in Puli, Nantou County, Taiwan) 01-Mar-2024 Corporate Asset Purchase Buildings and Property
Zhong Hui Lian He Ji Tuan (Certain Property and a Parcel of Land Chengdu, China) 14-Aug-2023 Secondary Transaction - Private Buildings and Property
Biokey 08-Feb-2019 Merger/Acquisition Biotechnology
Seene 25-Sep-2014 Merger/Acquisition Accessories
OCIS 26-Jul-2007 Merger/Acquisition Other Commercial Services
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

ABVC Biopharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view ABVC Biopharma’s complete esg history, request access »

ABVC Biopharma Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Biokey Fremont, CA 2000
AiBtl BioPharma Fremont, CA

ABVC Biopharma FAQs

  • When was ABVC Biopharma founded?

    ABVC Biopharma was founded in 1990.

  • Where is ABVC Biopharma headquartered?

    ABVC Biopharma is headquartered in Fremont, CA.

  • What is the size of ABVC Biopharma?

    ABVC Biopharma has 19 total employees.

  • What industry is ABVC Biopharma in?

    ABVC Biopharma’s primary industry is Drug Discovery.

  • Is ABVC Biopharma a private or public company?

    ABVC Biopharma is a Public company.

  • What is ABVC Biopharma’s stock symbol?

    The ticker symbol for ABVC Biopharma is ABVC.

  • What is the current stock price of ABVC Biopharma?

    As of 20-Nov-2026 the stock price of ABVC Biopharma is $0.87.

  • What is the current market cap of ABVC Biopharma?

    The current market capitalization of ABVC Biopharma is $23.4M.

  • Who are ABVC Biopharma’s competitors?

    Cidara Therapeutics, Nektar Therapeutics, Genentech, Novartis, and Bright Angel Therapeutics are some of the 7 competitors of ABVC Biopharma.

  • What is ABVC Biopharma’s annual earnings per share (EPS)?

    ABVC Biopharma’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process